Abstract:The association between Extracellular Vesicles (EVs) and Small Vessel Disease (SVD) might aid in the accurate early diagnosis and prognosis of acute ischemic stroke (AIS). This may be crucial for implementing the appropriate care plan and follow-up measures to limit the risk of permanent damage and prevent future occurrences. The purpose of the present study was to investigate the connection between circulating levels of EVs from various cellular origins and AIS severity biomarkers, established risk factors, and the presence of SVD as determined by noninvasive MRI imaging.The count of total circulating medium-size EVs and their phenotyping according to cellular origins were determined by flow cytometry analysis in platelet-free plasma from healthy volunteers and patients with AIS. Then, the relationship between the circulating of EVs to SVD and other risk factors was studied.When compared with controls, AIS patients exhibited a significantly higher number of circulating EVs originating from the endothelial cells, platelets, activated platelets, erythrocytes, and granulocytes. Multinomial logistic regression analysis showed a strong association between increased numbers of EVs derived from activated platelets (CD62P+) and erythrocytes (CD235a+) and the odds risk of AIS. However, it was found that a one-unit increase in CD235a+ EVs is associated with a 0.77-unit decrease in the odds of having SVD. Most AIS patients with SVD had hypertension, white matter ischemia, silent infarct, Basis Pontis ischemia, and cerebral microbleeds. However, the most significant risk for SVD was found in patients with hypertension on admission. Patients with hypertension on admission were 9.33 times more likely to have SVD than patients without hypertension on admission.Our findings underscore the value of circulating EVs as biomarkers of cell activation and thrombosis in AIS. Furthermore, our findings suggest a potential pathophysiological role for EVs in the onset and development of SVD and an interrelationship with major risk factors for AIS such as hypertension. Altogether, the association of EVs and non-invasive MRI imaging assessment of SVD presence may represent a novel combined approach for the identification of individuals with the highest risk of AIS and patients with the highest odds of recurrent stroke. This study was made possible by Qatar National Research Fund [grant No. NPRP11S-0114-180289]. The statements made herein are solely the responsibility of the authors. This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Extracellular Vesicles and Ischemic Stroke

Therapeutic potential of microglia-derived extracellular vesicles in ischemic stroke

Roles of Extracellular Vesicles in Cerebral Protection of Ischemic Stroke

Revolutionizing Ischemic Stroke Diagnosis and Treatment: The Promising Role of Neurovascular Unit-Derived Extracellular Vesicles

Extracellular vesicles: Mediators of microenvironment in hypoxia-associated neurological diseases

Exosomes and ischemic stroke

Neuroserpin and Extracellular Vesicles in Ischemic Stroke: Partners in Neuroprotection?

Exosomes in pathogenesis, diagnosis, and therapy of ischemic stroke

The role of small extracellular vesicles in cerebral and myocardial ischemia—Molecular signals, treatment targets, and future clinical translation

Advancing stroke therapy: innovative approaches with stem cell-derived extracellular vesicles

Engineered Extracellular Vesicles for Drug Delivery in Therapy of Stroke

Extracellular Vesicles as Delivery Shippers for Noncoding RNA‐Based Modulation of Angiogenesis: Insights from Ischemic Stroke and Cancer

Utilizing engineered extracellular vesicles as delivery vectors in the management of ischemic stroke: a special outlook on mitochondrial delivery

Exosomal microRNAs as Potential Biomarkers and Therapeutic Agents for Acute Ischemic Stroke: New Expectations

Observing Extracellular Vesicles Originating from Endothelial Cells in Vivo Demonstrates Improved Astrocyte Function Following Ischemic Stroke via Aggregation-Induced Emission Luminogens

The role and therapeutic potential of exosomes in ischemic stroke

Extracellular Vesicles in Cardiovascular Diseases: from Pathophysiology to Diagnosis and Therapy.

The Relationship of Circulating Extracellular Vesicles to Small Vessel Disease in Acute Ischemic Stroke

A Novel Perspective on Ischemic Stroke: A Review of Exosome and Noncoding RNA Studies

Role of extracellular vesicles in neurodegenerative diseases

Exosomes as biomarkers and therapeutic measures for ischemic stroke